Dasatinib vs Ipilimumab

## Dasatinib vs Ipilimumab: Overview

This comparison examines the pharmacological differences between **Dasatinib** and **Ipilimumab**.

## Mechanism of Action

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

## Pharmacokinetics

**Half-life**: Dasatinib — N/A; Ipilimumab — 14.7 days.

## Chemical Properties

**Type**: Dasatinib — Small molecule; Ipilimumab — Antibody.